Fresenius Medical Care AG FMS
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 51.81% | 64.46% | 91.29% | 12.94% | 25.83% |
| Total Depreciation and Amortization | 0.64% | 0.22% | -1.64% | -1.33% | -3.03% |
| Total Amortization of Deferred Charges | 31.05% | 31.05% | 31.05% | -7.63% | -7.63% |
| Total Other Non-Cash Items | 542.66% | 203.93% | 181.64% | 131.91% | 63.86% |
| Change in Net Operating Assets | -71.63% | -65.97% | -59.50% | -35.04% | 375.38% |
| Cash from Operations | 9.24% | 21.45% | 19.37% | 13.49% | 36.31% |
| Capital Expenditure | -58.96% | -46.04% | -38.46% | -5.43% | -4.31% |
| Sale of Property, Plant, and Equipment | -2.27% | 34.97% | 25.09% | 9.41% | -40.86% |
| Cash Acquisitions | 35.29% | -92.40% | -2,432.21% | -40.25% | -303.20% |
| Divestitures | 34.88% | -66.99% | -65.45% | -53.47% | -77.29% |
| Other Investing Activities | -65.15% | 57.20% | 52.23% | 98.49% | -529.70% |
| Cash from Investing | -65.10% | -570.85% | -760.52% | -539.88% | -14,091.81% |
| Total Debt Issued | 4.68% | 4,242.50% | 1,115.79% | 927.05% | 2,415.32% |
| Total Debt Repaid | 11.81% | 5.30% | 21.46% | -15.43% | -13.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.94% | -27.60% | -27.60% | -27.60% | -27.60% |
| Other Financing Activities | -84.23% | -85.98% | -86.71% | -165.95% | -50.49% |
| Cash from Financing | -84.85% | 23.48% | 41.28% | 5.14% | 34.77% |
| Foreign Exchange rate Adjustments | 49.28% | -1,428.14% | -685.88% | -30.22% | -202.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -209.67% | 247.46% | 285.98% | 28.13% | 362.32% |